comparemela.com

Latest Breaking News On - Needle free - Page 1 : comparemela.com

diabetes: No more painful insulin shots: Hyderabad company develops oral insulin spray for diabetes

Hyderabad-based NiedlFree Technologies has developed a needle-free oral insulin spray called Ozulin, offering a painless alternative for diabetes treatment. The company has obtained global patents for Ozulin in over 40 countries and has applied for permission to conduct safety studies. NiedlFree Technologies is also working on oral and nasal sprays for cancer, osteoporosis, and Alzheimer s.

Business newsBreaking news eventsLatest news updatesEconomic timesEconomic times news appDaily market updatesLive businessTransgene biotekNiedlfree technologiesOral insulin sprayDiabetes treatmentNeedle freeInsulin shotOral insulinDiabetes insulin

Here s Why You Could Be Giving Yourself—Or Someone Else—A Flu Shot Next Year

If approved, AstraZeneca’s nasal spray vaccine would become the first flu vaccine authorized for self-administration in the U.S.

United statesUnited kingdomIskra reicLisa glasserDrug administrationCenters for diseaseFlumist quadrivalentDisease controlFlu vaccine worksWay most people dont appreciateScientific americanNasal sprayNeedle freeSelf administered

FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative

ARS Pharmaceuticals chief executive Richard Lowenthal said the company is “very surprised” and “deeply disappointed” by the FDA’s decision.

Oak brookUnited statesRichard lowenthalZachary rubinDrug administration onDrug administrationOak brook allergistsFood and drug administrationArs pharmaceuticalsNeedle freeAllergic reaction

Liquid-based, Needle-Free Injector Market Facts, Future Scenarios, Growth and Analytical Insights 2032

Liquid based needle-free injectors market report provides an extensive analysis of the current and emerging market trends and dynamics

United statesPawan kumarBusiness intelligence solutionsInternational technologyNational medical productsEndo internationalAerospace defenseEnergy powerLife sciencesEuropean pharma groupStrategic developmentAntares pharmaSemiconductor electronicsMarket researchNeedle free injector marketBioject medical technologies

Coming in From the Cold: Needle-free Patch Technology for Mrna Vaccines Aims to End Need for Frozen Storage and Improve Access

CEPI to provide up to USD4.3 million (AUD6.4 million) to Vaxxas to advance development of its high-density microarray patch for mRNA vaccines. Vaxxas

United statesRichard hatchettDavid hoeyJane haltonAustralian government innovation investment fundUnited states biomedical advanced researchUniversity of queenslandDays missionDevelopment authorityOneventures innovation fundCoalition for epidemic preparedness innovationsEpidemic preparedness innovationsVaxxas chief executive officerMiddle east respiratory syndromeRift valley feverBrandon capital partners

vimarsana © 2020. All Rights Reserved.